Literature DB >> 18360193

Common and specific elements of psychosocial treatments for bipolar disorder: a survey of clinicians participating in randomized trials.

David J Miklowitz1, Guy M Goodwin, Mark S Bauer, John R Geddes.   

Abstract

BACKGROUND: There are 14 randomized trials that indicate the benefits of various adjunctive psychosocial interventions for bipolar disorder. Efficient planning of future interventions requires identification of the common, putatively active components of these treatments. We investigated whether different forms of psychotherapy consisted of overlapping versus modality-specific ingredients.
METHODS: We identified five categories of active psychosocial treatment in 14 trials: cognitive-behavioral therapy (CBT; 4 studies), family psychoeducation (5 studies), interpersonal and social rhythm therapy (IPSRT; 2 studies), individual psychoeducation (3 studies), and group psychoeducation (5 studies). In this study, 31 investigators and therapists who participated in these trials completed a questionnaire in which they rated the frequency of 17 treatment strategies in their active and treatment-as-usual (TAU) conditions. A content analysis of the results of this questionnaire was then done, in which the active treatments were compared with each other and with TAU on the frequency of use of each strategy.
RESULTS: The active modalities were distinguished from TAU by more frequent use of problem-solving and interventions to enhance patients' ability to cope with the stigma of mental illness. With regard to specific approaches, CBT made frequent use of cognitive restructuring and self-rated mood charts. The signature features of IPSRT-regulation of sleep/wake cycles and daily routines-were also regular features in the CBT and group psychoeducation interventions. Communication skills training was a distinctive feature of family treatments.
CONCLUSIONS: Whereas active psychosocial interventions for bipolar disorder have common ingredients, they can also be distinguished from each other and from TAU by the degree to which specific strategies are emphasized. Future research should compare the treatment ingredients identified in this study in terms of their ability to bring about clinical change.

Entities:  

Mesh:

Year:  2008        PMID: 18360193      PMCID: PMC2603054          DOI: 10.1097/01.pra.0000314314.94791.c9

Source DB:  PubMed          Journal:  J Psychiatr Pract        ISSN: 1527-4160            Impact factor:   1.325


  22 in total

1.  Collaborative care for bipolar disorder: part I. Intervention and implementation in a randomized effectiveness trial.

Authors:  Mark S Bauer; Linda McBride; William O Williford; Henry Glick; Bruce Kinosian; Lori Altshuler; Thomas Beresford; Amy M Kilbourne; Martha Sajatovic
Journal:  Psychiatr Serv       Date:  2006-07       Impact factor: 3.084

2.  A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence.

Authors:  Roger D Weiss; Margaret L Griffin; Monika E Kolodziej; Shelly F Greenfield; Lisa M Najavits; Dennis C Daley; Heidi Ray Doreau; John A Hennen
Journal:  Am J Psychiatry       Date:  2007-01       Impact factor: 18.112

3.  Collaborative care for bipolar disorder: Part II. Impact on clinical outcome, function, and costs.

Authors:  Mark S Bauer; Linda McBride; William O Williford; Henry Glick; Bruce Kinosian; Lori Altshuler; Thomas Beresford; Amy M Kilbourne; Martha Sajatovic
Journal:  Psychiatr Serv       Date:  2006-07       Impact factor: 3.084

Review 4.  The nature and treatment of depression in bipolar disorder: a review and implications for future psychological investigation.

Authors:  Warren Mansell; Francesc Colom; Jan Scott
Journal:  Clin Psychol Rev       Date:  2005-09-02

Review 5.  Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.

Authors:  Lakshmi N Yatham; Sidney H Kennedy; Claire O'Donovan; Sagar Parikh; Glenda MacQueen; Roger McIntyre; Verinder Sharma; Peter Silverstone; Martin Alda; Philippe Baruch; Serge Beaulieu; Andree Daigneault; Roumen Milev; L Trevor Young; Arun Ravindran; Ayal Schaffer; Mary Connolly; Chris P Gorman
Journal:  Bipolar Disord       Date:  2005       Impact factor: 6.744

6.  Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program.

Authors:  David J Miklowitz; Michael W Otto; Ellen Frank; Noreen A Reilly-Harrington; Stephen R Wisniewski; Jane N Kogan; Andrew A Nierenberg; Joseph R Calabrese; Lauren B Marangell; Laszlo Gyulai; Mako Araga; Jodi M Gonzalez; Edwin R Shirley; Michael E Thase; Gary S Sachs
Journal:  Arch Gen Psychiatry       Date:  2007-04

7.  Relapse prevention in patients with bipolar disorder: cognitive therapy outcome after 2 years.

Authors:  Dominic H Lam; Peter Hayward; Edward R Watkins; Kim Wright; Pak Sham
Journal:  Am J Psychiatry       Date:  2005-02       Impact factor: 18.112

8.  Does adjunctive family therapy enhance recovery from bipolar I mood episodes?

Authors:  Ivan W Miller; David A Solomon; Christine E Ryan; Gabor I Keitner
Journal:  J Affect Disord       Date:  2004-11-01       Impact factor: 4.839

9.  Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial.

Authors:  Jan Scott; Eugene Paykel; Richard Morriss; Richard Bentall; Peter Kinderman; Tony Johnson; Rosemary Abbott; Hazel Hayhurst
Journal:  Br J Psychiatry       Date:  2006-04       Impact factor: 9.319

10.  Long-term effectiveness and cost of a systematic care program for bipolar disorder.

Authors:  Gregory E Simon; Evette J Ludman; Mark S Bauer; Jürgen Unützer; Belinda Operskalski
Journal:  Arch Gen Psychiatry       Date:  2006-05
View more
  25 in total

Review 1.  Sleep disturbance as transdiagnostic: consideration of neurobiological mechanisms.

Authors:  Allison G Harvey; Greg Murray; Rebecca A Chandler; Adriane Soehner
Journal:  Clin Psychol Rev       Date:  2010-04-24

2.  A randomized pilot study of psychotherapy and quetiapine for the acute treatment of bipolar II depression.

Authors:  Holly A Swartz; Ellen Frank; Yu Cheng
Journal:  Bipolar Disord       Date:  2012-03       Impact factor: 6.744

Review 3.  The clinical significance of creativity in bipolar disorder.

Authors:  Greg Murray; Sheri L Johnson
Journal:  Clin Psychol Rev       Date:  2010-05-27

4.  The longitudinal course of bipolar disorder as revealed through weekly text messaging: a feasibility study.

Authors:  Jedediah M Bopp; David J Miklowitz; Guy M Goodwin; Will Stevens; Jennifer M Rendell; John R Geddes
Journal:  Bipolar Disord       Date:  2010-05       Impact factor: 6.744

Review 5.  A critical update on psychological interventions for bipolar disorders.

Authors:  Eduard Vieta; Isabella Pacchiarotti; Marc Valentí; Lesley Berk; Michael Berk; Jan Scott; Francesc Colom
Journal:  Curr Psychiatry Rep       Date:  2009-12       Impact factor: 5.285

Review 6.  Annual Research Review: The state of implementation science in child psychology and psychiatry: a review and suggestions to advance the field.

Authors:  Nathaniel J Williams; Rinad S Beidas
Journal:  J Child Psychol Psychiatry       Date:  2018-08-25       Impact factor: 8.982

Review 7.  Bipolar depression in pediatric populations : epidemiology and management.

Authors:  Victoria E Cosgrove; Donna Roybal; Kiki D Chang
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022

8.  Contemporary Approaches to Frequent Mood Monitoring in Bipolar Disorder.

Authors:  Aiysha Malik; Guy M Goodwin; Emily A Holmes
Journal:  J Exp Psychopathol       Date:  2012-10-06

Review 9.  Treatment of bipolar disorder.

Authors:  John R Geddes; David J Miklowitz
Journal:  Lancet       Date:  2013-05-11       Impact factor: 79.321

Review 10.  [Guideline-adherent psychiatric psychotherapeutic treatment of bipolar disorders : Which resources are needed?]

Authors:  A Pfennig; J Conell; P Ritter; D Ritter; E Severus; T D Meyer; M Hautzinger; J Wolff; F Godemann; A Reif; M Bauer
Journal:  Nervenarzt       Date:  2017-03       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.